Euro AAA–AA Healthcare & Pharmaceuticals Corporate Bond Yields (EUR)
Fitted spot curve as of 2026-11-18
https://bondscovery.com/yield-curve/eur-corporate-aaa-aa-healthcare-pharmaceuticals
Euro AAA–AA Healthcare & Pharmaceuticals Corporate Bond Yields (EUR) as of 2026-11-18: 10Y at 4.11%, fitted curve 9M–30Y (3.12%–4.55%), 51 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 9M | 3.12% | — |
| 12M | 3.27% | 3.75% |
| 18M | 3.43% | 3.72% |
| 2Y | 3.49% | 3.72% |
| 3Y | 3.59% | 3.79% |
| 4Y | 3.68% | 3.97% |
| 5Y | 3.76% | 4.14% |
| 6Y | 3.84% | 4.30% |
| 7Y | 3.92% | 4.45% |
| 8Y | 3.99% | 4.58% |
| 9Y | 4.05% | 4.69% |
| 10Y | 4.11% | 4.79% |
| 15Y | 4.34% | 4.97% |
| 20Y | 4.46% | 5.06% |
| 30Y | 4.55% | 4.94% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 3.49% and the 10-year 4.11%, a 10Y−2Y spread of +62 bp — positively sloped — as of 2026-11-18. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-11-18 |
|---|---|
| 2Y | 3.49% |
| 10Y | 4.11% |
| 10Y − 2Y | +62 bp |
Bonds in this curve
A selection of 30 of the 51 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Novartis | 3.01% | 2027-09-30 | 1.12% | XS1585010074 |
| Novo Nordisk Finance | 3.29% | 2027-09-30 | 1.12% | XS2449330179 |
| Abbott | 3.41% | 2027-11-19 | 0.38% | XS2076155105 |
| Roche Holding | 3.34% | 2027-12-04 | 3.31% | XS2726331932 |
| Sanofi SA | 3.44% | 2028-04-05 | 1.12% | FR0013144003 |
| Novo Nordisk Finance | 3.53% | 2028-05-27 | 2.38% | XS3002552993 |
| Novo Nordisk Finance | 3.53% | 2028-06-04 | 0.12% | XS2348030425 |
| Johnson & Johnson | 3.44% | 2028-11-20 | 1.15% | XS1412266816 |
| Novo Nordisk Finance | 3.60% | 2029-01-21 | 3.12% | XS2820454606 |
| Novo Nordisk Finance | 3.63% | 2029-02-20 | 2.50% | XS3232921240 |
| Sanofi SA | 3.65% | 2029-06-23 | 2.62% | FR0014010MQ4 |
| Roche Holding | 3.47% | 2029-08-27 | 3.20% | XS2592088236 |
| Novartis | 3.50% | 2030-08-14 | 1.38% | XS1769041192 |
| Novo Nordisk Finance | 3.71% | 2030-08-27 | 2.88% | XS3002553298 |
| Novartis | 3.80% | 2032-01-13 | 3.10% | XS3366248279 |
| Novo Nordisk Finance | 3.88% | 2032-02-20 | 3.00% | XS3232937162 |
| Johnson & Johnson | 3.74% | 2032-06-01 | 3.20% | XS2821718488 |
| Sanofi SA | 3.79% | 2032-06-23 | 3.00% | FR0014010MR2 |
| Novo Nordisk Finance | 4.00% | 2033-05-27 | 3.12% | XS3002553538 |
| Sanofi SA | 3.86% | 2034-03-21 | 1.25% | FR0013409851 |
| Novo Nordisk Finance | 4.10% | 2034-05-21 | 3.38% | XS2820460751 |
| Novo Nordisk Finance | 4.08% | 2035-02-20 | 3.38% | XS3232944531 |
| Johnson & Johnson | 3.96% | 2035-05-20 | 1.65% | XS1412266907 |
| Johnson & Johnson | 4.04% | 2036-06-01 | 3.35% | XS2821719023 |
| Johnson & Johnson | 4.10% | 2037-02-26 | 3.35% | XS3005214799 |
| Novartis | 4.20% | 2041-05-13 | 4.00% | XS3366248600 |
| Roche Holding | 4.48% | 2044-05-03 | 3.56% | XS2813211617 |
| Johnson & Johnson | 4.34% | 2044-06-01 | 3.55% | XS2821719536 |
| Johnson & Johnson | 4.43% | 2045-02-26 | 3.60% | XS3005215093 |
| Johnson & Johnson | 4.54% | 2055-02-26 | 3.70% | XS3005215689 |